rheumatoid arthritis

Rheumatoid arthritis is a chronic autoimmune disorder that primarily affects joints, causing inflammation, pain, and stiffness. The condition is characterized by symmetric polyarthritis, with the hands, feet, wrists, and knees being commonly affected. Florence Nightingale, Jean-Martin Charcot, and Robert Graves are notable figures who have contributed to the understanding of this condition. Rheumatoid arthritis affects approximately 1% of the global population, with World Health Organization (WHO) and American College of Rheumatology (ACR) providing diagnostic criteria.

Signs and symptoms

The signs and symptoms of rheumatoid arthritis include morning stiffness, joint pain and swelling, fatigue, and loss of function. Patients often experience symmetric joint involvement, with the metacarpophalangeal joints and proximal interphalangeal joints being commonly affected. David Atlas and Felson have described the clinical features of rheumatoid arthritis in detail. Some patients may also experience extra-articular manifestations, such as rheumatoid nodules, vasculitis, and osteoporosis, which can be diagnosed using X-ray and magnetic resonance imaging (MRI).

Causes and risk factors

The exact causes of rheumatoid arthritis are still unknown, but several risk factors have been identified. HLA-DRB1 and HLA-DQB1 genes have been associated with an increased risk of developing rheumatoid arthritis. Smoking and obesity are also recognized as significant risk factors. Environmental factors, such as infections and hormonal changes, may also play a role in triggering the onset of rheumatoid arthritis. Peter Medawar and Frank Macfarlane Burnet have contributed to our understanding of the genetic and environmental factors underlying autoimmune diseases.

Pathophysiology

Rheumatoid arthritis is characterized by an abnormal immune response, which leads to inflammation and joint destruction. Cytokines, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1), play a crucial role in the pathogenesis of rheumatoid arthritis. Synovial fibroblasts and T cells are also involved in the inflammatory process. Janus kinase (JAK) and signal transducer and activator of transcription (STAT) signaling pathways are important in the regulation of immune responses in rheumatoid arthritis. Ronald G. Crystal has made significant contributions to the understanding of the molecular mechanisms underlying rheumatoid arthritis.

Diagnosis

The diagnosis of rheumatoid arthritis is based on a combination of clinical, laboratory, and imaging findings. Rheumatoid factor (RF) and anti-citrullinated protein antibody (anti-CCP) are commonly used laboratory tests to support the diagnosis. Imaging studies, such as X-ray, ultrasound, and MRI, can help assess joint damage and inflammation. American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR) have developed classification criteria for rheumatoid arthritis.

Management

The management of rheumatoid arthritis involves a multidisciplinary approach, including pharmacological and non-pharmacological interventions. Disease-modifying antirheumatic drugs (DMARDs), such as methotrexate and sulfasalazine, are commonly used to slow disease progression. Biologic agents, such as tumor necrosis factor inhibitors and interleukin-6 inhibitors, have also been shown to be effective in reducing inflammation and joint damage. Physical therapy and occupational therapy can help improve function and quality of life. Centers for Disease Control and Prevention (CDC) and Arthritis Foundation provide guidelines for the management of rheumatoid arthritis.

Epidemiology

Rheumatoid arthritis affects approximately 1% of the global population, with a higher prevalence in developed countries. World Health Organization (WHO) estimates that rheumatoid arthritis affects over 20 million people worldwide. The condition is more common in women than men, with a female-to-male ratio of approximately 3:1. Nordic countries and Australia have reported higher prevalence rates of rheumatoid arthritis. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) supports research into the epidemiology and management of rheumatoid arthritis.

Category:Rheumatology